MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

The team, publishing in the journal Advanced Science, used a new drug discovery screening platform technology, called the ...

Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening ...

Lariocidin, a peptide made by bacteria living in soil, was effective against several different microbes responsible for deadly infections. UIC researchers working with collaborators at McMaster ...

GLP-1 receptor agonists are peptide-based drugs used for managing diabetes and for weight loss, but these treatments have had shortages recently. Now, through a process called in vivo antibody ...

Therapy receives FDA Orphan Drug Designation for PEP-010for treatment of Pancreatic CancerParis (France), March 17, 2025 – ...